1-methyladenosine,
N(1)-methyladenosine,
1-Methyladenosine,
15763-06-1,
N1-Methyladenosine,
CHEBI:16020,
Adenosine, 1-methyl-,
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-imino-1-methyl-purin-9-yl)tetrahydrofuran-3,4-diol,
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-imino-1-methylpurin-9-yl)oxolane-3,4-diol,
MFCD00038421,
NSC 92165,
N1-Methyl-D-adenosine,
AC1L1DAV,
Adenosine, N,6-didehydro-1,6-dihydro-1-methyl-,
CHEMBL1866485,
SCHEMBL19553541,
CTK8F3395,
GFYLSDSUCHVORB-IOSLPCCCSA-N,
GN7727,
AKOS030241121,
ZINC100053615,
Adenosine, 1-methyl- (VAN) (8CI),
NCGC00163305-01,
HY-113081,
CS-0059513,
C02494,
K-4948,
Adenosine, N,6-didehydro-1,9-dihydro-1-methyl-,
C-48712,
Adenosine, N,6-didehydro-1,6-dihydro-1-methyl- (9CI),
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-imino-1-methyl-1H-purin-9(6H)-yl)tetrahydrofuran-3,4-diol,
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-imino-1-methyl-6,9-dihydro-1H-purin-9-yl)oxolane-3,4-diol,
alpha-Vetivone,
CID27476,
C11-H15-N5-O4,
1-Methyladenosine, 98% - 250MG 250mg,
(2R,3R,4S,5R)-2-(6-Amino-1-methyl-1H-purin-9(2H)-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol,
M1A,